The overarching scientific goal for the Neuro-Oncology Research Program is to develop prevention, better diagnosis, and treatment of primary malignant brain tumors in children and adults.
Our mission is:
To conduct molecular genetics and epidemiologic studies to identify the cause and relevant tumor suppressor and driver oncogenes in all the major types of adult and childhood malignant brain tumors.
To establish innovative and predictive model systems that accurately identify active and inactive therapeutic compounds before clinical use.
To invent and translate novel therapeutics into clinical trials incorporating innovative trial designs and techniques.
To maintain a comprehensive brain tumor repository in concert with the Duke Cancer Institute (DCI).
To train the next generation of neuro-oncologists—MD, Ph.D., and MD/Ph.D. students; postdoctoral fellows; residents; surgical, medical, and pediatric clinical neuro-oncologists.
To promote research in the supportive care of patients with primary brain tumors